John James Verser Iii, LMFT | |
4 Butterfly Ln, Bloomsbury, NJ 08804-3517 | |
(908) 479-1222 | |
(908) 479-1172 |
Full Name | John James Verser Iii |
---|---|
Gender | Male |
Speciality | Marriage & Family Therapist |
Location | 4 Butterfly Ln, Bloomsbury, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730399874 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 37FI00101300 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
John James Verser Iii, LMFT 4 Butterfly Ln, Bloomsbury, NJ 08804-3517 Ph: (908) 479-1222 | John James Verser Iii, LMFT 4 Butterfly Ln, Bloomsbury, NJ 08804-3517 Ph: (908) 479-1222 |
News Archive
In this Kaiser Health News story, produced in collaboration with USA Today, KHN staff writer Phil Galewitz writes about how the so-called young invincibles would be impacted by pending health reform proposals.
Fewer women are getting hysterectomies in every state across the country. Instead, more patients may be choosing minimally invasive procedures or other alternatives to handle issues like pelvic pain and fibroids over a traditional abdominal hysterectomy, new Michigan Medicine research suggests.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received final approval from the United States Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for lidocaine topical patch 5%, the generic equivalent to Endo's Lidoderm.
The Endocrine Society and Society for Women's Health Research (SWHR) are co-sponsoring a Congressional briefing on July 10 to examine the need to include more female subjects in preclinical and clinical biomedical research - a move that could revolutionize medical research and scientific discovery.
› Verified 5 days ago